192 related articles for article (PubMed ID: 25130537)
1. The PAX2-null immunophenotype defines multiple lineages with common expression signatures in benign and neoplastic oviductal epithelium.
Ning G; Bijron JG; Yamamoto Y; Wang X; Howitt BE; Herfs M; Yang E; Hong Y; Cornille M; Wu L; Hanamornroongruang S; McKeon FD; Crum CP; Xian W
J Pathol; 2014 Dec; 234(4):478-87. PubMed ID: 25130537
[TBL] [Abstract][Full Text] [Related]
2. Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube.
Chen EY; Mehra K; Mehrad M; Ning G; Miron A; Mutter GL; Monte N; Quade BJ; McKeon FD; Yassin Y; Xian W; Crum CP
J Pathol; 2010 Sep; 222(1):110-6. PubMed ID: 20597068
[TBL] [Abstract][Full Text] [Related]
3. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
4. In vitro and in vivo correlates of physiological and neoplastic human Fallopian tube stem cells.
Yamamoto Y; Ning G; Howitt BE; Mehra K; Wu L; Wang X; Hong Y; Kern F; Wei TS; Zhang T; Nagarajan N; Basuli D; Torti S; Brewer M; Choolani M; McKeon F; Crum CP; Xian W
J Pathol; 2016 Mar; 238(4):519-530. PubMed ID: 26415052
[TBL] [Abstract][Full Text] [Related]
5. Through the glass darkly: intraepithelial neoplasia, top-down differentiation, and the road to ovarian cancer.
Crum CP; Herfs M; Ning G; Bijron JG; Howitt BE; Jimenez CA; Hanamornroongruang S; McKeon FD; Xian W
J Pathol; 2013 Dec; 231(4):402-12. PubMed ID: 24030860
[TBL] [Abstract][Full Text] [Related]
6. Fallopian tube correlates of ovarian serous borderline tumors.
Laury AR; Ning G; Quick CM; Bijron J; Parast MM; Betensky RA; Vargas SO; McKeon FD; Xian W; Nucci MR; Crum CP
Am J Surg Pathol; 2011 Dec; 35(12):1759-65. PubMed ID: 22089527
[TBL] [Abstract][Full Text] [Related]
7. PAX2-null secretory cell outgrowths in the oviduct and their relationship to pelvic serous cancer.
Quick CM; Ning G; Bijron J; Laury A; Wei TS; Chen EY; Vargas SO; Betensky RA; McKeon FD; Xian W; Crum CP
Mod Pathol; 2012 Mar; 25(3):449-55. PubMed ID: 22080059
[TBL] [Abstract][Full Text] [Related]
8. Reduced PAX2 expression in murine fallopian tube cells enhances estrogen receptor signaling.
Colina JA; Varughese P; Karthikeyan S; Salvi A; Modi DA; Burdette JE
Carcinogenesis; 2020 Jul; 41(5):646-655. PubMed ID: 31271204
[TBL] [Abstract][Full Text] [Related]
9. LEF1 is preferentially expressed in the tubal-peritoneal junctions and is a reliable marker of tubal intraepithelial lesions.
Schmoeckel E; Odai-Afotey AA; Schleißheimer M; Rottmann M; Flesken-Nikitin A; Ellenson LH; Kirchner T; Mayr D; Nikitin AY
Mod Pathol; 2017 Sep; 30(9):1241-1250. PubMed ID: 28664938
[TBL] [Abstract][Full Text] [Related]
10. [Expansion of secretory cells in the fallopian tubal epithelium in the early stages of the pathogenesis of ovarian serous carcinomas].
Asaturova AV; Ezhova LS; Faizullina NM; Adamyan LV; Khabas GN; Sannikova MV
Arkh Patol; 2017; 79(3):10-18. PubMed ID: 28631711
[TBL] [Abstract][Full Text] [Related]
11. PAX2 function, regulation and targeting in fallopian tube-derived high-grade serous ovarian cancer.
Modi DA; Tagare RD; Karthikeyan S; Russo A; Dean M; Davis DA; Lantvit DD; Burdette JE
Oncogene; 2017 May; 36(21):3015-3024. PubMed ID: 27991925
[TBL] [Abstract][Full Text] [Related]
12. Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomas.
Soong TR; Howitt BE; Miron A; Horowitz NS; Campbell F; Feltmate CM; Muto MG; Berkowitz RS; Nucci MR; Xian W; Crum CP
J Pathol; 2018 Nov; 246(3):344-351. PubMed ID: 30043522
[TBL] [Abstract][Full Text] [Related]
13. Endometrioid Tubal Intraepithelial Neoplasia (E-TIN) of the Fallopian Tube: A Case Series.
Hecht JL; Lin DI; Garrett L
Int J Gynecol Pathol; 2020 Nov; 39(6):552-557. PubMed ID: 31855954
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a Novel Endometrioid Carcinogenic Sequence in the Fallopian Tube With Unique Beta-Catenin Expression.
Brouwer J; Strickland KC; Ning G; Schmelkin CB; Kolin DL; Hecht J; Nucci MR; Mourits MJ; Xian W; Crum CP
Int J Gynecol Pathol; 2020 Mar; 39(2):163-169. PubMed ID: 31574529
[TBL] [Abstract][Full Text] [Related]
15. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].
Wen J; Shi JL; Shen DH; Chen YX; Song QJ
Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451
[TBL] [Abstract][Full Text] [Related]
16. The conceptual advances of carcinogenic sequence model in high-grade serous ovarian cancer.
Kobayashi H; Iwai K; Niiro E; Morioka S; Yamada Y; Ogawa K; Kawahara N
Biomed Rep; 2017 Sep; 7(3):209-213. PubMed ID: 28811894
[TBL] [Abstract][Full Text] [Related]
17. A candidate precursor to serous carcinoma that originates in the distal fallopian tube.
Lee Y; Miron A; Drapkin R; Nucci MR; Medeiros F; Saleemuddin A; Garber J; Birch C; Mou H; Gordon RW; Cramer DW; McKeon FD; Crum CP
J Pathol; 2007 Jan; 211(1):26-35. PubMed ID: 17117391
[TBL] [Abstract][Full Text] [Related]
18. The fallopian tube, "precursor escape" and narrowing the knowledge gap to the origins of high-grade serous carcinoma.
Soong TR; Howitt BE; Horowitz N; Nucci MR; Crum CP
Gynecol Oncol; 2019 Feb; 152(2):426-433. PubMed ID: 30503267
[TBL] [Abstract][Full Text] [Related]
19. [Morphologic features of fallopian tubal epithelium in pelvic high-grade serous carcinoma].
Zhao RJ; Wang YY; Li Z; Wu KY; Kong LF; Zheng WX
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):542-547. PubMed ID: 28810294
[No Abstract] [Full Text] [Related]
20. High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease.
Zhai Y; Wu R; Kuick R; Sessine MS; Schulman S; Green M; Fearon ER; Cho KR
J Pathol; 2017 Sep; 243(1):16-25. PubMed ID: 28608929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
